CorMedix misled investors about its sole product, Neutrolin, and shares in the company fell 81 cents on a trading day last week when a news article reported on the inflation, a class claims.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.





